Ide. Further cholinergic aspects of carotid body chemotransduction of hypoxia in cats. J. Appl. Physiol. 82(3): 819-827, 1997.-From the 1930s into the 1970s, the role of acetylcholine (ACh) in the carotid body's chemotransduction of hypoxia was debated. Since the late 1970s, the issue has been pursued only intermittently or not at all. The purpose of this study was to test again with a new preparation the hypothesis that ACh is an excitatory neurotransmitter in the cat carotid body's chemotransduction of hypoxia. We tested the effect of the specific nicotinic blocker mecamylamine and the muscarinic blocker of all five muscarinic receptors, atropine. We further tested the effects of M 1 and M 2 muscarinic-receptor blockers. The carotid body region was selectively perfused with hypoxic Krebs-Ringer bicarbonate (KRB) solutions that were blocker free or contained varying doses of the blockers. Both mecamylamine and atropine reduced the response to hypoxic KRB in a dose-related manner. The M 2 muscarinicreceptor blockers gallamine and AFDX 116 increased the response to hypoxic KRB, whereas the M 1 muscarinicreceptor blocker pirenzepine reduced the response to hypoxic KRB. These data are consistent with an excitatory role for ACh in the carotid body chemotransduction of hypoxia in the cat.
THE IDENTITY of the excitatory neurotransmitter(s) in the carotid body's response to hypoxia has been a matter of controversy over several decades. Exogenously applied acetylcholine (ACh) clearly stimulates the cat carotid body. And several early investigators (11, 30, 31) , using techniques such as acetylcholinesterase blockers, generated data supportive of an excitatory role for endogenously released ACh in the carotid body of the cat during hypoxia. In the 1970s, Eyzaguirre and colleagues (12) (13) (14) (15) (16) (17) published several papers that provided strong evidence that, in the cat, ACh was an excitatory neurotransmitter in the carotid body's chemotransduction of several stimuli. However, data unsupportive of an excitatory role for ACh during hypoxic chemotransduction have also been presented by several investigators (9, 10, 25, 28, 35, 36, 40) . The controversy has remained unresolved and only intermittently examined since the late 1970s.
The present study represents a continuation of our efforts to provide some new insight into answering the question ''Does ACh play an excitatory role in the chemotransduction of hypoxia in the cat carotid body? '' In previous studies it has been shown (20) (21) (22) that when the isolated carotid body in situ was transiently and selectively perfused with a hypoxic Krebs-Ringerbicarbonate solution (KRB) containing a combination of muscarinic and nicotinic blockers, the neural response, compared with the response to the blocker-free hypoxic KRB, was reduced in a dose-related way. The study reported herein describes carotid body neural responses to perfusions of hypoxic KRB containing either the nicotinic blocker alone or the muscarinic blocker alone. We also report the neural response to a perfusion of hypoxic KRB that contained either an M 1 or an M 2 muscarinic-receptor blocker.
METHODS

Preparation
Cats (3.0-4.0 kg) were anesthetzied with pentobarbital sodium (32 mg/kg). After ,1 h, the animal's anesthesia was maintained with a bolus of chloralose (20 mg/kg iv), followed by a sustained infusion (2 mg · kg 21 ·h 21 ). Body temperature was maintained at 37-38°C with a heating blanket (model K-20, American Hamilton Aquamatic Module). A tracheal cannula was inserted. A femoral arterial catheter was inserted for the measuring of blood pressure and for sampling of blood to determine PCO 2 , PO 2 , and pH, and a femoral venous catheter was inserted for the administration of drugs and fluids. Blood samples were measured with a Radiometer BMS 3Mk2 Blood MicroSystem. During the experiment, the animals' physiological condition, as judged from arterial pH, PCO 2 and PO 2 values, and arterial blood pressure, was maintained best if they were ventilated on oxygen-enriched room air and were kept hydrated with 3-5 ml · kg 21 ·h 21 of Ringer solution to which 3.1 mg/ml of sodium lactate were added. If necessary, arterial pH was adjusted with an infusion (1 ml/min) of 1 M NaHCO 3 in a 2.5% glucose saline solution until pH returned to normal.
A perfusion loop was inserted into the common carotid artery, and the remaining vasculature in the area was ligated except for the lingual, the external carotid artery, and the venous outflow of the carotid body. The whole carotid sinus nerve was used for recording chemoreceptor activity after the baroreceptor input was removed by gently crushing the carotid sinus and gently and briefly applying heat from an ophthalmological cautery to the sinus. The nerve was put under warm mineral oil. Neural activity was recorded from bipolar platinum-iridium electrodes connected to a Grass P15 preamplifier. The amplified neural activity was displayed on an oscilloscope (Hitachi V-302 F) and integrated (Grass wide-band AC preamplifier and integrator model 7P3C). This unit was a capacity-coupled differential preamplifier with frequency-response characterisitics enabling it to record neural activity. Full-wave rectification circuits ensured amplitude linearity of integration. The integrated trace displayed on the polygraph (Grass 79E) was proportional to the average level of the ongoing signal generated by the activity in the carotid sinus nerve. Femoral blood pressure, amplified raw nerve activity, and blood pressure in the common carotid artery loop were also recorded on the polygraph.
Except for 10-12 perfusions of KRB for 120-180 s each, the animal perfused its own carotid body with its own arterial blood throughout the experiment. When a perfusion was to be made, the snares around common and external carotid arteries were drawn tightly, the stopcock was turned, and KRB was perfused into the loop. The composition of KRB was (mM) 120 NaCl; 3.5 KCl; 1.8 CaCl 2 ; 0.6 MgCl 2 ; 20 glucose; 0.56 NaH 2 PO 4 ; and 22 NaHCO 3 . Pressure in the loop during the KRB perfusion replicated the preceding arterial pressure, showing systolic and diastolic components generated by the perfusion pump. The perfusion escaped the carotid body area by the carotid body venous outflow and the lingual artery, which was fitted with a variable resistance. KRB was perfused at 5-8 ml/min via a water-jacketed catheter that preserved the perfusate's temperature at 37-38°C.
Two types of perfusions were made. In the first, while the animal was being ventilated on oxygen-enriched room air, a perfusion of hypoxic, blocker-free or hypoxic, blocker-containing KRB was made into the common carotid artery. In the second, the animal was again ventilated on oxygen-enriched room air. A perfusion of blocker-free, hypoxic KRB was made for 1 min from the first syringe. At the 1-min mark, this syringe was switched off, and immediately a second, containing equally hypoxic KRB with or without the blocker, was turned on. The two-syringe perfusion technique allowed each animal to serve as its own control without any intervening time period and possible change in neural output from the carotid body. Figure 1 presents an example of syringes switched repeatedly after perfusions of 20-60 s.
Drugs used in the experiments were AFDX 116 (a generous gift from Dr. Allyson Fryer), atropine (free base; Sigma Chemical), gallamine triethiodide (Sigma Chemical), mecamylamine hydrochloride (N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride; Sigma Chemical), and pirenzepine dihydrochloride (Sigma Chemical). These were dissolved in KRB.
Mean values 6SE are presented. Statistical analysis was made by using analysis of variance (ANOVA) with Duncan's new multiple-range test for determining significant differences among the means. Student's paired or unpaired t-tests were also used. P values were judged to be significant when they were at the 0.05 or better level. Figure 2 presents the responses of the carotid body to a perfusion of hypoxic KRB that was either free of or contained increasing doses of mecamylamine. Statistical comparison of the data extended from 30 to 120 s and showed the response values at each time point during the 134 and 670 µM mecamylamine perfusions to be significantly different from the corresponding time points of the other two perfusions. The 67 µM perfusion differed from the control perfusion at all time points except at 100 and 120 s.
RESULTS
Mecamylamine
Atropine
The carotid body's response to hypoxic KRB was reduced in a dose-related manner by inclusion of atropine in the perfusate. The mean values at the various time points (Fig. 3) were significantly different from each other.
By way of a summary presentation, Fig. 4 shows the response to the different concentrations of mecamylamine as whole treatments (i.e., the response during the entire perfusion period). The histograms are significantly different from each other at the 0.05 level except for the difference between the control and 67 µM mecamylamine histograms, which narrowly misses the P , 0.05 level (P 5 0.073). This probably reflects the influence of time points 100 and 120 s in Fig. 2 .
In two experiments, a lower dose of atropine was used with a different technique (Fig. 5 ). For 60 s the first syringe infused hypoxic KRB, followed by a second syringe perfusing hypoxic KRB that either contained or was free from one of the two doses of atropine. Interestingly, ANOVA testing of the data in only two experiments indicated that there was a significant difference between the time points from 30-s mark of the second perfusion onward.
AFDX 116, Gallamine, and Pirenzepine
Because atropine blocks all known muscarinic receptors, further pharmacological testing was done in an effort to determine whether M 1 and M 2 muscarinicreceptor activity could be detected. AFDX 116, an M 2 muscarinic-receptor blocker, was tested in four experiments. Figure 6 presents mean values from five perfusions in three animals in which one syringe with blocker-free or blocker-containing hypoxic KRB was used in normoxic cats. All time points are significantly different, except at 10 s.
To test the impact of gallamine or pirenzepine on increased neural activity produced by hypoxic KRB, double perfusion-type experiments were performed (Fig.  7) . Hypoxic KRB was delivered from the first syringe for 60 s followed by a 70-s perfusion from the second syringe containing equally hypoxic KRB that was blocker free like the first or contained either gallamine (a second M 2 muscarinic-receptor blocker; 450 µM) or pirenzepine (an M 1 muscarinic-receptor blocker; 400 µM). The second perfusate was blocker free or gallamine containing in seven experiments and pirenzepine containing in four of those same seven experiments. ANOVA demonstrated significant differences between the hypoxic KRB and the hypoxic1gallamine KRB perfusions at each of the 10-s time intervals. An unpaired t-test analysis showed significant differences between the control and pirenzepine perfusions starting at the 40-s mark. We assume that the differences between gallamine and pirenzepine are also significant at each of the time points.
In five subsequent experiments in the normoxic cat (Fig. 8) , a single-perfusion technique was used to confirm our observation that, with this technique, pirenzepine acted more slowly than gallamine. Paired t-test comparisons showed that there were significant differences from the 30-s mark onward.
DISCUSSION
Summary
Using a perfusion technique that restricts the cholinergic blockers to the area of the carotid body, we have observed in vivo a dose-related depression of the carotid body neural response to a 2-min perfusion of hypoxic KRB containing either mecamylamine (67-670 µM) or atropine (78-1,570 µM). We have also observed that when either of two M 2 muscarinic-receptor blockers (gallamine or AFDX 116) was included in the hypoxic KRB perfusate, the carotid body neural response was greater than that to the blocker-free hypoxic KRB. Also, when pirenzepine, an M 1 muscarinic-receptor blocker was included, the response to hypoxic KRB was less than that to the blocker-free hypoxic KRB. These data support an excitatory role for ACh in the chemotransduction of hypoxia in the cat carotid body. Furthermore, the data suggest the presence of M 1 and M 2 muscarinic receptors in the carotid body of the cat that function during a hypoxic challenge.
Critique of Methods
Preparation. The overall integrity of the preparation appeared to remain good throughout the experiment. Examination of the carotid body after perfusions showed no structural damage, at least at the level of light microscopy, but there was a mild infiltration of inflammatory cells. This is not surprising given the 6-to 8-h duration of the experiment and the fact that sterile conditions were not maintained. The application of the stimulus was local, transient, and reversible. This seems to have contributed to the overall viability of the preparation, and it provided exact information as to the concentration of the blockers delivered to the carotid body vasculature. However, the responses of the carotid bodies to these perfusates were probably not the equilibrium responses.
We have chosen to use a whole nerve recording as opposed to the few-fiber recording for practical reasons but with experimental justification. Single-or few-fiber preparations are difficult to maintain in the face of drawing up on snares (especially on the external carotid artery), adjusting the variable resistor on the lingual arterial catheter (to ensure proper pressure in the carotid body area), and the turning of stopcocks. However, previous studies (18, 19) have compared the neural output of a whole nerve recording minus the baroreceptor component (removed by thermal and mechanical treatment of the carotid sinus area) in response to hypercapnia at different levels of hypoxia with the single-/few-fiber preparation's response to the same stimulus protocol. The results were qualitatively identical.
Protocol. In the application of a pharmacological agent to the vasculature of the carotid body to evaluate its ability to be excited or inhibited, a first consideration might be the passage of the agents from the vasculature to the putative structures involved in chemotransduction. The vasculature of the carotid body is extensive, and the passage of simple molecules like O 2 and CO 2 through membranes is rapid. However, Ross (39) , studying the cat carotid body with the electron microscope, reported an impressive number of layers between the endothelium of the capillaries and the synaptic cleft of the type I cell/apposed nerve fiber. According to Ross, no very intimate contact exists between the type I cells and the blood channels.
However, there seems to be little question that a large molecule can reach into the synaptic cleft. Woods (45) showed that horseradish peroxidase (HRP; molecular wt ,40,000) penetrated to all intercellular spaces in the carotid bodies of 100-g rats. What is unclear is how the HRP got to these spaces. Woods describes his observation as a ''paradox'' in that the HRP could be observed in the intercellular clefts after only 30 s, whereas it had not left normal capillaries by 10 min. Hence, although the HRP molecule can occupy the spaces, it is impossible, as Woods himself states, ''simply from these experiments to make calculations of the minimum time it might take some other substance . . . to pass from the blood to the receptor.'' Hence, it seems that the responses of the carotid body to blockercontaining hypoxic perfusates over the first 2 min should be considered nonequilibrium responses.
Agreement/Disagreement With Other Studies
The results reported in this study, although consistent with some reports (11-17, 30, 31) , fail to be consistent with others (9, 10, 25, 28, 35, 36, 40) . Presently, it is difficult to account completely for these differences. Sampson (40) was unable to find that intravenous injections of mecamylamine reduced the excitation of the carotid bodies due to arterial injections of NaCN, acid, and hypoxic blood. In a more quantitative approach, McQueen (35) reported results virtually identical to those of Sampson (40) . On the other hand, the studies of Eyzaguirre and Zapata (15) (16) (17) showed mecamylamine to be effective in reducing several forms of excitation of the carotid body. Sampson (40) suggested that perhaps part of the difference was due to the in vivo preparation with normal circulation vs. the superfused in vitro preparation of Eyzaguirre and Zapata (15) (16) (17) http://jap.physiology.org/ many vessels in the area of the carotid sinus have been ligated, the major blood supply to the carotid body is untouched. Hence it would seem that circulation to and within the carotid body itself was no less normal than the circulation in the studies of Sampson (40) and McQueen (35) . However, here the results are consistent with the data of Eyzaguirre and Zapata (15) (16) (17) .
Perhaps the concentrations in the studies of Sampson (40) and McQueen (35) were too low. In McQueen's study, the mean weight of the cats was 2.9 kg. A reasonable estimate of extracellular fluid would be 0.580 liter. A homogeneous distribution of the 250 µg/kg to 6 mg/kg would create a concentration in the extracellular fluid of 6.1 and 147 µM, respectively. It is puzzling, therefore, that neither Sampson (40) nor McQueen (35) saw any impact on either resting or stimulated neural activity when they used concentrations of mecamylamine in the range of 150 µM in extracellular fluid. Some of the perfusates used in the study reported here that were in this concentration range (67 and 134 µM) did reduce the response to hypoxic KRB consistently. Perhaps the assumption of a homogeneous distribution of mecamylamine is incorrect or a significant fraction of mecamylamine became attached to plasma protein. Kurz and his colleagues (29) reported that ,39% of a total dose of atropine was bound to plasma protein in adult human subjects. Hence in the preparations of Sampson (40) and McQueen (35) the synaptic receptors in the carotid body may never have been exposed to the concentrations calculated above. We know the concentrations delivered to the carotid body vasculature in our studies, although we, too, do not know the tissue concentrations of the blockers. With the high concentrations delivered, we saw the effect in a matter of seconds. This is consistent with the concept that a high concentration of cholinergic blockers focused on the appropriate site may be required to produce the depression (23).
Antagonist Concentration
A major concern, however, is the possibility that the high micromolar concentration of antagonists used in this study may have generated their effects simply by way of a nonspecific inhibition. Clear descriptions of nonspecific inhibition or depression are not plentiful, making the addressing of this possibility somewhat difficult. But Taylor and Insel (41) give the following description: ''. . . a depression of all cellular excitability by affecting the energy charge, physicochemical state of the membrane, or capacity to generate second messengers. . . .'' In an earlier study (21) data were reported pertinent to the possibility of nonspecific inhibition. First, the carotid body area was perfused with hypoxic KRB containing both 402 µM mecamylamine and 942 µM atropine. Integrated baroreceptor activity, recorded from the carotid sinus nerve, retained the same amplitude and pattern it had shown when the carotid body was perfused with blocker-free hypoxic KRB. Integrated chemoreceptor activity, however, was markedly reduced. Then the preparation was perfused with hypoxic KRB containing only 300 µM lidocaine. Lidocaine inhibited both baroreceptor and chemoreceptor activities in the whole nerve recording in 25 s. These results suggested that atropine and mecamylamine did not exercise an anesthetic effect, which we presumed was the explanation for the effect of the lidocaine.
We have no information suggesting that any of the agents used as blockers of cholinergic receptors exert an effect on the energy charge of glomus cells or neurons, nor is there any information addressing the issue of whether they impede the generation of second messengers.
Finally, if the effect of the antagonists was due to a nonspecific inhibition or depression in the carotid body, it would be difficult to explain why including either of the two M 2 -receptor antagonists gallamine and AFDX 116 in the hypoxic KRB generated a larger response than the blocker-free hypoxic KRB, whereas including the M 1 muscarinic-receptor antagonist pirenzepine generated a smaller response than the blocker-free hypoxic KRB.
Receptor Type and Location
Considerations such as those mentioned above warrant searching for other explanations that are based on the presence of cholinergic receptors in the cat carotid body. Data support this presence. In the cat, Dinger and colleagues (6, 7) have reported the presence of a-bungarotoxin (a-Bgt)-binding sites on type I cells, type II cells, and, by inference, on sympathetic nerves supplying the vasculature of the carotid body. They were not visible on the chemoreceptor afferent fibers of the carotid sinus nerve in the carotid body. However, their presence has been reported (20) on an extra-carotid body segment of whole carotid sinus nerve, appearing in somewhat heavier concentration on each side of a ligature that had been in place for 10 h.
However, it is important to point out that, in the species studied, neuronal nicotinic (nACh) receptors are pentameres made up of a-and b-subunits. To date, at least eight a (a 2 -to a 9 -)-and three b (b 2 -to b 4 -)-subunits have been cloned from chick, rat, and human neuronal tissues. The a-Bgt-binding site contains a 7 -subunits (a 8 -and a 9 -subunits are also sensitive to a-Bgt). It is now well accepted, as was acknowledged by Dinger et al. in 1981 (6) and by Hirano et al. in 1992 (26) , that this nACh receptor is not involved in synaptic neuronal transmission; it is extrasynaptic and frequently presynaptic (33) . It could function as a cation channel (46) . Indeed, in Xenopus oocytes nACh receptors made up of five a 7 -subunits have a Ca 21 /Na 1 permeability ratio of 20:1 (34) . The most frequently studied nACh receptors involved in neuronal transmission in the central and peripheral nervous systems are composed of three a 2 -, a 3 -, or a 4 -subunits with two b 2 -or b 4 -subunits. The permeability coefficient (K D ), inhibitory constant (K i ), 50% effective concentration, and 50% inhibitory concentration (IC 50 ) values, expressive of the affinity of these receptors for agonists and antagonists, vary greatly. b-Subunits seem to codetermine the sensitivity of rat nACh receptors to some antagonsists (1). (7) also reported that in the in vitro cat carotid body 50 nM a-Bgt reduced by 50% the hypoxiaor nicotine-generated release of [ 3 H]dopamine. It also reduced significantly the stimulus-evoked discharges recorded from the carotid sinus nerve. Gonzalez and colleagues (24) described the inhibitory effects on catecholamine release and on discharge in their earlier study (7) as being ''incomplete.'' Using nicotine-evoked [ 3 H]catecholamine release, they compared the inhibitory effects of 50 µM mecamylamine and 100 nM a-Bgt. Mecamylamine reduced the release by 92%, whereas a-Bgt reduced the release by only 56%. They concluded that nACh receptors and a-Bgt-binding sites are not ''completely identical.'' They felt their results ''call into question earlier interpretations based solely on a-Bgt binding in the organ, and rekindle uncertainty regarding the localization of nACh receptors on type I cells versus CSN afferent terminals.'' Recently, we have reported data strongly suggesting the presence of the a 4 -subunit of the nACh receptor on the type I cell and possibly on cell bodies and some fibers in the petrosal ganglion (27) . However, there may be a variety of nACh receptors in the carotid body. This is currently being investigated.
As mentioned above, the affinity characteristics (K D , IC 50 , and so on) of the nACh receptors for agonists and antagonists vary greatly. Dinger and colleagues (7) reported a K D of 5.7 nM for the carotid body a-Bgtbinding site. However, Zorumski et al. (47) , using whole cell voltage-clamp techniques in cultured postnatal rat hippocampal neurons, found that 100 µM mecamylamine reduced the fast current generated by 1 mM ACh by 69%, and 1 mM reduced it by 89%. Mulle et al. (37) compared the electrophysiological and pharmacological characteristics of nACh receptors located at pre-and postsynaptic sites within the medial habenula and interpeduncular nucleus system in the rat brain slice preparation. The IC 50 values for presynaptic nACh receptors on afferent axons to the interpedunular nucleus (50 µM nicotine stimulus) were (in µM) 2 mecamylamine, 4 hexamethonium, 250 dihydro-berythroidine, and 200 curare. Whiting and Lindstrom (44) , characterizing nACh receptors in the human brain, found the K i for mecamylamine to inhibit the binding of DL-[ 3 H]nicotine was .10 23 M. Finally, it seems important to remember that more than one type of nicotinic receptor can be found in a given location. Vernallis and her colleagues (43) found in chick ciliary ganglia a class of nACh receptors, predominantly synaptic, which contained receptors having at least three types of subunits; they were encoded by the a 3 -, b 4 -, and a 5 -ACh receptor genes. They also showed a class of extrasynaptic ACh receptors on the same neurons; it contained the a 7 -subunits but lacked the a 3 -, b 4 -, and a 5 -subunits.
In summary, across several species there is a variety of nACh receptors that have widely varying affinity/ inhibitory characteristics (4, 32, 34) . In any one location, the nACh receptors are not necessarily homogeneous. We are only beginning to look for these nACh receptors in the carotid body of the cat. On the basis of the intrinsic characteristics of the nACh receptor briefly described above, it seems quite premature to assign the inhibition generated by cholinergic antagonists in the present study only to nonspecific effects.
With regard to muscarinic receptors, Dinger et al. (5, 8) and Hirano et al. (26) have reported [ 3 H]quinuclidinyl benzilate-binding sites in both the rabbit and cat carotid bodies. In the cat they describe the failure of the carotid body to respond to the muscarinic agonist pilocarpine. Our use of gallamine, AFDX 116, and pirenzepine confirms the presence of M 1 and M 2 muscarinic receptors in the cat carotid body. Our data suggest that whereas the M 2 receptor seems to inhibit the response to hypoxic KRB, the M 1 receptor seems to enhance the response to hypoxic KRB. [ 3 H]quinuclidinyl benzilate-binding sites are reported to be plentiful in the cat carotid body (26) . If, in the cat carotid body, the combination of characteristics that determine the neural output due to the muscarinic M 1 (e.g., number, distribution, affinity, access by exogenously delivered agents) matched the combination for the M 2 muscarinic receptor, then the failure of pilocarpine to produce any response would be understandable.
A final consideration regarding the use of micromolar concentrations of cholinergic antagonists to block either nicotinic or muscarinic receptors seems pertinent. Several studies have reported that the concentrations of neurotransmitters in the synaptic cleft can reach millimolar levels. Udgaonkar and Hess (42) reported that in aplysia ACh released from the presynaptic cell within 0.5-1 ms of the arrival of an action potential can reach a concentration at the postsynaptic membrane of ,300 µM within a few microseconds. Nishi et al. (38) found that the concentration of liberated ACh per impulse in an eserinized lumbar sympathetic ganglion of the toad could reach 840 µM. Clements et al. (3) found that glutamate peaked at 1.1 mM in the clefts of cultured hippocampal synapses from rats. Clements (2) has recently reviewed several classes of central synapses to find broad agreement that the average concentration of transmitter peaks in the range 1-5 mM with a biphasic clearance, having time constants of ,100 µs and 2 ms. The pulse of transmitter, although very brief, can prolong the time course of some synaptic currents and is enough to saturate certain postsynaptic receptors (e.g., g-aminobutyric acid, glycine, or N-methyl-Daspartate). Hence, if there are cholinergic receptors in the synaptic cleft between the type I cell and the apposed nerve fiber and if this synapse functions like so many others in the central and peripheral nervous systems, it is quite reasonable to postulate a need for a high level of antagonist to block the effects of endogenously released agonists.
Conclusion
At this point, every model has its shortcomings in trying to incorporate all the available data into an explanation of hypoxic chemotransduction in the carotid body of any species. What has been shown here are data consistent with an excitatory role for ACh during the chemotransduction of hypoxia in the cat 825 carotid body. If, on the basis of these pharmacological studies, one speculates that both the nACh receptors involved in neural transmission and the M 1 and M 2 muscarinic receptors are present both pre-and postsynaptically, several different models could be generated. However, further study is needed before any of them could claim a preferential position.
